EUVIMEDEUVIMED entdecken
Open Access

Clinical feature of cystoid macular degeneration in central serous chorioretinopathy

Sukanya Gorhe, Manpreet Kaur Chugh, Nikita Goel, Zubin D'Souza, Kumar Saurabh, Rupak Roy

Indian Journal of Ophthalmology · 2023

DOI: 10.4103/ijo.ijo_255_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Sukanya Gorhe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Aditya Birla Sankara Nethralaya, 147, Mukundapur, E.M. Bypass, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Macular Degeneration, Retinal Neovascularization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cystoid macular degeneration (CMD) is a feature of chronic central serous chorioretinopathy (CSCR). Present study intended to analyze the clinical presentation, risk factors, choroidal features, and outcome of CMD in CSCR.

Methods

This was a retrospective, record-based descriptive study, which included chronic CSCR eyes with CMD. Demographic profile and clinical history were obtained from medical records. Spectralis spectral domain optical coherence tomography (SDOCT; Heidelberg Engineering, Germany) was used for acquiring SDOCT images and for performing fluorescein angiography, indocyanine green angiography, and optical coherence tomography (OCT) angiography.

Results

The study included 101 eyes of 69 consecutive patients of CSCR having CMD. The mean age of patients was 56 ± 9.4 years (range 40–79 years), and majority (63, 91.3%) of the patients were male. Prior history of corticosteroid use was present in seven (10.1%) patients. Mean time interval between the first diagnosis of CSCR and appearance of CMD was 55.3 ± 33.9 months. CMD was located away from the fovea in majority of eyes (68, 67.3%). Mean subfoveal choroidal thickness was 396.71 ± 90.5 µm. Subretinal pigment epithelium choroidal neovascularization was noted in four (3.96%) eyes.

Conclusion

CMD appears as a late complication of CSCR and is usually present away from the fovea. Such eyes had thickened choroid and fewer cases had associated choroidal neovascularization. Further comparative studies would be needed to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyMacular DegenerationRetinal NeovascularizationHumansMaleFemaleAdultMiddle AgedAgedRetrospective StudiesChoroidTomography, Optical Coherence

Stichwörter der Autor:innen

Central serous chorioretinopathychoroidal neovascular membranecystoid macular degeneration

Autor:innen und Institutionen

  • Aditya Birla Sankara Nethralaya, 147, Mukundapur, E.M. Bypass, Kolkata, West Bengal, India.
  • BB Eye Foundation VIP, Shree Tower, RAA - 36, II, VIP Road, Raghunathpur, Rajarhat, Kolkata, West Bengal, India.

Zitieren

APA

Gorhe, S., Chugh, M. K., Goel, N., D'Souza, Z., Saurabh, K., & Roy, R. (2023). Clinical feature of cystoid macular degeneration in central serous chorioretinopathy. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_255_23

Vancouver

Gorhe S, Chugh MK, Goel N, D'Souza Z, Saurabh K, Roy R. Clinical feature of cystoid macular degeneration in central serous chorioretinopathy. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_255_23

BibTeX
@article{Gorhe2023,
  author = {Gorhe, Sukanya and Chugh, Manpreet Kaur and Goel, Nikita and D'Souza, Zubin and Saurabh, Kumar and Roy, Rupak},
  title = {Clinical feature of cystoid macular degeneration in central serous chorioretinopathy},
  journal = {Indian Journal of Ophthalmology},
  year = {2023},
  doi = {10.4103/ijo.ijo_255_23}
}
Kostenlos starten →